Onceweekly tirzepatide versus oncedaily insulin degludec as addon to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS3): a randomised, openlabel, parallelgroup, phase 3 trial
Reported experiences are mixed rather than uniform
When you eat and drink less, fluids and electrolytes can drop
Purity, claimed at 99% on the product labels, came in between 7.7% and 14.37% across tested batches
Enter your vial concentration and desired dose, and it tells you exactly how many units to draw
Once you reach a maintenance dosage, you will have regular interval check-ins to discuss your treatment and the appropriateness of new prescriptions